Genoma Espa

1
Genoma EspañaMesa Redonda
Carlos Romero-CamachoDirector de Recursos
Humanos BMS Iberia
29 Junio 2004
2
Nuestra Misión

• Prolongar y mejorar la vida humana ofreciendo
  productos farmacéuticos y de cuidado de la salud
  de la mas alta calidad

3
44,000 Empleados en 100 países 2003 Ventas
globales20.9 Billones
4
BMS EspañaDatos de la Compañía

• 811 empleados
• Ventas total grupo 493 mill. Euros en 2003
• (8 2002)
• 5º en Total Mercado Farmacéutico
• Líderes en Oncología y Virología
• 3ª Filial en Europa
• 7ª filial del grupo en el mundo30

5
Farmacia ID
Bristol-Myers SquibbPharmaceuticalResearch
Institute

• 5.400 personas en todo el mundo
• 4 grandes centros en Norte América
  interrelacionados con centros en todo el mundo
• 50 moléculas en desarrollo
• Inversión de 2.274 millones en ID en 2003
  (2.75 2002) 11 de las ventas

6
Principales Áreas de Investigación
Oncología
Virología
Inmunología
7
Candidate Producing
Our Comprehensive Network ofAlliances and
Partnerships
O U R I N T E R N A L D I S C O V E R Y
Discovery Technology

• Arcturus
• Athersys
• Celera Diagnostics
• Chiron
• Deltagen
• Exelixis
• Genomic Health

• Incyte
• Institute Gustave-Roussy
• Karolinska
• Lexicon Genetics
• Life Span
• Perlegen
• Pharmagene

• Princeton University
• Roche Diagnostics
• Sequitur
• Virtual Arrays
• Whitehead Institute
• Xenogen
• Yale University

8
Product Development Commercialization (PDC)
Phase IV
Lead Discovery
Target ID
Phase III
Phase IIb
Phase IIa
Phase I
Pre-clinical
Research after a drug has been approved
Research prior to testing a drug with human
subjects
Research conducted with human subjects
The PDC Process Creates Dialogue Between the
Scientific / Research, Manufacturing / Operations
and Commercial Sides of the Business
9
Key Decision Points
Decision Point 5 Go to Full Development (Phase
IIB or III)
Decision Point 1 Go to Early Discovery/Start of
the Process
Decision Point 6 Initiate Commercialization
Life Cycle Management
Decision Point 2 Go to Full Discovery
Decision Point 3 Go to Exploratory Development
Decision Point 7 Go to file
Decision Point 4 Go to First In Man
Decision Point 8 Go to Launch
10
Actividades de ID en 2003
INVESTIGACIÓN CLÍNICA - Administración ensayos
clínicos - Monitores

• ÁREAS TERAPÉUTICAS
• CARDIOVASCULAR
• ONCOLOGÍA
• ANTIVIRALES
• MEDICINA INTERNA
• - SNC
• - Dolor
• - Antibióticos

SERVICIOS MÉDICOS - Farmacovigilancia -
Información Médica - Farmacoeconomía -
Evaluación de resultados
52 personas (95 titulados superiores)
GESTIÓN DE LA CALIDAD Y PRODUCTIVIDAD
INVESTIGACIÓN CLÍNICA EN ESPAÑA PARA REGISTRO
INTERNACIONAL 553 centros, 3.083 pacientes
11
Actividades de ID en España
5,2 ()
5,8 ()
4,01 ()
3,7 ()
3,73 ()
() sobre Venta Directa
12
Programas de Excelencia
Medical Excellence
SalesEXCEL
13
Programas de Excelencia

• Perfiles de Posiciones Tareas y
  responsabilidades claras para las funciones
• Modelo de Competencias Claros requerimientos
  en cuanto a habilidades y comportamientos para
  cada posición
• Mapas de Carreras una guía claramente definida
  para la progresión profesional con diferentes
  opcones tanto locales, como en Europa u otros
  paises
• Programa de Formación y Desarrollo alineado con
  el perfil requerido y que capacite para todo lo
  anterior

14
Position Profiles y Funciones EJEMPLO
Position Profiles are mapped to a set of
physician roles these may be Core or
Secondary
Roles Roles that constitute EMEA physicians day
job these are further broken down into key
tasks and activities (these will vary by position)
Positions EMEA Medical physician positions
defined by the project
Core Roles Most important roles for a given
position key areas of focus
Secondary Roles Roles important to position, but
likely to account for less time than primary roles
15
Competencias
Drug Development Expertise
Compliance
Statistics Data Analysis
Medical / Scientific Excellence
Medical / Scientific Technical
Disease Area Knowledge
Product/ Brand Knowledge
Scientific Presentations Publications
MEDICAL TECHNICAL
Pricing, Re-imbursement Pharmacoeconomics
Customer Market Insight
BUSINESS
Managing Customers Internal Partners
Business
Cultural Diversity
Project Management
BMS CORE BEHAVIOURS
Communicates Directly
Directly Drives Performance
BMS Core Behaviours
Builds Alignment
Develops People
Leads Strategically
Energizes Others
Collaborates
16
EMEA Career Mapping Marketing Excellence
LEVEL
Small Market
Medium Market
Large Market
HQ/EMEA

4
4
Commercial VP Business Unit VP Commercial
Director
General Manager EMEA Brand Champion EMEA
General Manager


Country Manager Commercial Director Marketing
Director
Business Unit Director Marketing Director
General Manager Country Mgr
Marketing Dir Franchise EMEA


3
3
Commercial Director Business Unit
Director Marketing Director
.
Life Cycle Director

Business Unit Dir

Business Unit Manager Marketing Manager Group
Product Manager
Business Unit Mgr Marketing Mgr Country Group
Product Manager
BL Business Unit Mgr

2

2
Marketing Mgr Country Group Product Manager
Life Cycle Mgr Market Research Head
Senior Product Manager



Senior Product Manager
Senior Product Manager
Product Manager
Level 1
1
Product Manager Associate Product Manager
1

Associate Product Manager
Product Manager Associate Product Manager
Moving forward up-along-across

17
Ciclo de Evaluación del Rendimiento

• Business Goals
• Individual Objectives
• Areas of Focus in Standard Position Profile
• Competency Proficiency Profile Assessment
• Learning Development

ESTABLISHING CLEAR EXPECTATIONS
Talent Review Discussions

• Feedback gathered on Individual Objectives, Core
  BMS Behaviours and Med Ex Competencies at same
  time
• Learning Development Priorities continuously
  reassessed

ASSESSMENT EVALUATION
FEEDBACK COACHING

• Formal assessment continues to be on Individual
  Objectives Core BMS Behaviours
• Assessment against the Proficiency Profile for
  Position will underpin Talent Review discussions

18
Comportamientos Fundamentales BMS
LIDERA ESTRATÉGICAMENTE FIJA OBJETIVOS COMUNICA
DIRECTAMENTE IMPULSA EL DESMPEÑO COLABORA
ESTIMULA A OTROS DESARROLLA A LAS PERSONAS
19
Definición de las Competencias Técnicas y de
Negocio del programa Medical / Scientific
Excellence
20
Definición de las Competencias Técnicas y de
Negocio del programa Medical / Scientific
Excellence